Literature DB >> 9598313

Promoter sequence, expression, and fine chromosomal mapping of the human gene (MLP) encoding the MARCKS-like protein: identification of neighboring and linked polymorphic loci for MLP and MACS and use in the evaluation of human neural tube defects.

D J Stumpo1, R L Eddy, L L Haley, S Sait, T B Shows, W S Lai, W S Young, M C Speer, A Dehejia, M Polymeropoulos, P J Blackshear.   

Abstract

The MARCKS-like protein (MLP), also known as F52, MacMARCKS, or MARCKS-related protein, is a widely distributed substrate for protein kinase C (PKC). Recent studies using gene disruption in vivo have demonstrated the importance of both MARCKS and MLP to the development of the central nervous system; specifically, mice lacking either protein exhibit a high frequency of neural tube defects. We isolated a genomic clone for human MLP and discovered a directly linked polymorphism (MLP1) useful for genetic linkage analysis. The MLP promoter was 71% identical over 433 bp to that of the corresponding mouse gene, Mlp, with conservation of many putative transcription factor-binding sites; it was only 36% identical over 433 bp to the promoter of the human gene, MACS, which encodes the MLP homologue MARCKS. This 433-bp fragment drove expression of an MLP-beta-galactosidase transgene in a tissue-specific and developmental expression pattern that was similar to that observed for the endogenous gene, as shown by in situ hybridization histochemistry. In contrast to MACS, the MLP and Mlp promoters contain a TATA box approximately 40 bp 5' of the presumed transcription initiation site. MLP was localized to chromosome 1p34-->1pter by analysis of human-mouse somatic cell hybrid DNA and to 1p34 by fluorescence in situ hybridization. Radiation hybrid mapping of MLP placed it between genetic markers D1S511 (LOD > 3.0) and WI9232. MACS was localized to 6q21 between D6S266 (LOD > 3.0) and AFM268uh5 by the same technique. We tested the novel MLP1 polymorphism and the MACS flanking markers in a series of 43 Caucasian simplex families in which the affected child had a lumbosacral myelomeningocele. We found no evidence of linkage disequilibrium, suggesting that these loci were not major genes for spina bifida in these families. Nonetheless, the identification of linked and neighboring polymorphisms for MACS and MLP should permit similar genetic studies in other groups of patients with neural tube defects and other neurodevelopmental abnormalities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9598313     DOI: 10.1006/geno.1998.5247

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  11 in total

Review 1.  Current perspectives on the genetic causes of neural tube defects.

Authors:  Patrizia De Marco; Elisa Merello; Samantha Mascelli; Valeria Capra
Journal:  Neurogenetics       Date:  2006-08-29       Impact factor: 2.660

2.  Coupled global and targeted proteomics of human embryonic stem cells during induced differentiation.

Authors:  Anastasia K Yocum; Theresa E Gratsch; Nancy Leff; John R Strahler; Christie L Hunter; Angela K Walker; George Michailidis; Gilbert S Omenn; K Sue O'Shea; Philip C Andrews
Journal:  Mol Cell Proteomics       Date:  2008-02-26       Impact factor: 5.911

3.  MARCKS-like protein, a membrane protein identified for its expression in developing neural retina, plays a role in regulating retinal cell proliferation.

Authors:  Jing Zhao; Tomonori Izumi; Kazuto Nunomura; Shinya Satoh; Sumiko Watanabe
Journal:  Biochem J       Date:  2007-11-15       Impact factor: 3.857

Review 4.  Cross-talk unfolded: MARCKS proteins.

Authors:  Anna Arbuzova; Arndt A P Schmitz; Guy Vergères
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

Review 5.  Human neural tube defects: developmental biology, epidemiology, and genetics.

Authors:  Eric R Detrait; Timothy M George; Heather C Etchevers; John R Gilbert; Michel Vekemans; Marcy C Speer
Journal:  Neurotoxicol Teratol       Date:  2005-03-05       Impact factor: 3.763

6.  Development-associated myristoylated alanine-rich C kinase substrate phosphorylation in rat brain.

Authors:  Hideo Hamada; Yun-Ling Zhang; Akiko Kawai; Fang Li; Yasuhide Hibino; Yutaka Hirashima; Masanori Kurimoto; Nakamasa Hayashi; Ichiro Kato; Shunro Endo; Koichi Hiraga
Journal:  Childs Nerv Syst       Date:  2003-01-30       Impact factor: 1.475

Review 7.  MARCKS and Lung Disease.

Authors:  Mary K Sheats; Qi Yin; Shijing Fang; Joungjoa Park; Anne L Crews; Indu Parikh; Brian Dickson; Kenneth B Adler
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

Review 8.  Pathophysiological roles of myristoylated alanine-rich C-kinase substrate (MARCKS) in hematological malignancies.

Authors:  Deepak Narayanan Iyer; Omar Faruq; Lun Zhang; Nasrin Rastgoo; Aijun Liu; Hong Chang
Journal:  Biomark Res       Date:  2021-05-06

Review 9.  MARCKS and MARCKS-like proteins in development and regeneration.

Authors:  Mohamed El Amri; Una Fitzgerald; Gerhard Schlosser
Journal:  J Biomed Sci       Date:  2018-05-22       Impact factor: 8.410

Review 10.  X MARCKS the spot: myristoylated alanine-rich C kinase substrate in neuronal function and disease.

Authors:  Jon J Brudvig; Jill M Weimer
Journal:  Front Cell Neurosci       Date:  2015-10-13       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.